Vistagen Therapeutics (VTGN) Cash from Financing Activities (2010 - 2026)
Vistagen Therapeutics (VTGN) reported Cash from Financing Activities of $909,000 for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 38.9% from $1.49 million a year earlier.
Powered by 
Analysis
Vistagen Therapeutics (VTGN) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Vistagen Therapeutics' Cash from Financing Activities came in at $30.39 million, up 559.3% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $30.97 million, up 864.8% from FY2025.
- Cash from Financing Activities has a five-year compound annual growth rate of -23.0% (FY2021 to FY2026).
- By fiscal year, Cash from Financing Activities came in at $3.21 million in FY2025 (-97.5%), $128.4 million in FY2024, -$1.04 million in FY2023 and $10.48 million in FY2022 (-90.8%).
- Five-year quarterly Cash from Financing Activities spans a low of -$397,400 in fiscal Q4 2023 and a high of $93.73 million in fiscal Q3 2024.
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at -$283,000 (Q4 2026), $2.11 million (Q3 2026) and $27.65 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Vistagen Therapeutics | 13.76 Mn | 13.76 Mn | - | 909,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 909,000.00 |
| Mar 31, 2026 | -283,000.00 |
| Dec 31, 2025 | 2.11 Mn |
| Sep 30, 2025 | 27.65 Mn |
| Jun 30, 2025 | 1.49 Mn |
| Mar 31, 2025 | 1.95 Mn |
| Dec 31, 2024 | 1.17 Mn |
| Jun 30, 2024 | 88,000.00 |
| Mar 31, 2024 | -380,000.00 |
| Dec 31, 2023 | 93.73 Mn |
| Sep 30, 2023 | 34.18 Mn |
| Jun 30, 2023 | 875,000.00 |
| Mar 31, 2023 | -397,400.00 |
| Dec 31, 2022 | -304,100.00 |
| Sep 30, 2022 | -334,000.00 |
| Jun 30, 2022 | -5,500.00 |
| Mar 31, 2022 | 23,700.00 |
| Dec 31, 2021 | 2.12 Mn |
| Sep 30, 2021 | 7.35 Mn |
| Jun 30, 2021 | 991,400.00 |
API Access
Vistagen Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=VTGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();